NeuroSense Therapeutics Reports New Data: Statistically Significant Clinical Efficacy in Phase 2b ALS Trialnews2023-12-14T14:58:40+00:00December 14th, 2023|Medical Device News Magazine|
Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combination Studies of ORSERDU® (Elacestrant) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2023 San Antonio Breast Cancer Symposiumnews2023-12-11T16:59:25+00:00December 11th, 2023|Medical Device News Magazine|
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolismnews2023-12-07T13:55:02+00:00December 7th, 2023|Medical Device News Magazine|
Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Studynews2023-12-07T11:30:56+00:00December 7th, 2023|Medical Device News Magazine|
Stoke Therapeutics Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndrome at the American Epilepsy Society 2023 Annual Meetingnews2023-12-01T15:14:35+00:00December 1st, 2023|Medical Device News Magazine|
Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patientsnews2023-12-01T13:03:36+00:00December 1st, 2023|Medical Device News Magazine|
Research Team at UNC Validates PixCell Medical’s HemoScreen as Game-Changer for Clozapine Monitoring in Psychiatrynews2023-11-29T14:59:57+00:00November 29th, 2023|Medical Device News Magazine|
Clinical Validation Data Published in CHEST Demonstrate that Veracyte’s Percepta Nasal Swab Test Improves Lung Cancer Risk Assessment for Patients with Lung Nodulesnews2023-11-29T13:40:42+00:00November 29th, 2023|Medical Device News Magazine|
BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosisnews2023-11-29T13:30:13+00:00November 29th, 2023|Medical Device News Magazine|
InGeneron Announces Critical In-Depth Analysis of the Results from a Recently Published 480-Patient Phase III Knee Osteoarthritis Trialnews2023-11-21T15:24:32+00:00November 21st, 2023|Medical Device News Magazine|
